Skip to content

Clinical trials

Observational Leukemia, Myeloid, Acute trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Observational Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20131
20161
20171
20194
20203
20211
20225
20233
20245
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Unknown status9
Completed8
Active, not recruiting3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gruppo Italiano Malattie EMatologiche dell'Adulto7
Fondazione IRCCS Policlinico San Matteo di Pavia3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS3
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2
Ciceri Fabio2
A.O.U. Città della Salute e della Scienza1
AbbVie1
Azienda Ospedaliera San Giovanni Battista1
Catholic University of the Sacred Heart1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute31
Infections2
Myelodysplastic Syndromes2
Neoplasms2
Recurrence2
Aspergillosis1
Blast Crisis1
Breast Carcinoma In Situ1
Breast Neoplasms1
Breast Neoplasms, Male1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.